# Exploratory Study of the Effects of Omega-3-acid Ethyl Esters on the Lipid and Lipoprotein Profile in the Blood

> **NCT02839902** · PHASE4 · COMPLETED · sponsor: **Takeda** · enrollment: 53 (actual)

## Conditions studied

- Hyperlipidemia

## Interventions

- **DRUG:** TAK-085
- **OTHER:** Not treated with omega-3-acid ethyl esters

## Key facts

- **NCT ID:** NCT02839902
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-27
- **Primary completion:** 2017-08-30
- **Final completion:** 2017-08-30
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2019-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02839902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02839902, "Exploratory Study of the Effects of Omega-3-acid Ethyl Esters on the Lipid and Lipoprotein Profile in the Blood". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02839902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*